ThetaPal ThetaPal

Manufacturing / Biological Products, Except Diagnostic Substances

Prime Medicine, Inc.

PRME

$4.26

+$0.38 (+9.77%)

Price as of Nov 13, 2026 22:20 UTC

46%

IV Rank

114.7%

Implied Volatility

Mar 01

Next Earnings

Technical Signals as of Nov 13
Mixed
2 of 5

Trend

  • Above 20-day average $4.20
  • Above 50-day average $3.88

Momentum

  • Golden cross (50/200) —
  • Momentum cross (20/50) 25d ago

Volume

  • Below-average volume 1.0x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Activity & Greeks

Implied volatility, flow, and dealer positioning from the options market.

Put/Call Ratio

0.19

Bullish skew

Implied Volatility

114.7%

1% percentile

IV vs Realized

Options cheap

30d HV 144.1%

Options Heat Map

Delta-risk grid for PRME options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

0 buys 0 sells
Date Insider Title Type Shares Value Since Trade
Jun 05, 2026 NELSEN ROBERT Grant 75,000 $0 +39.5%
Jun 05, 2026 Foster-Cheek Kaye I Grant 75,000 $0 +39.5%
Jun 05, 2026 Kelly Michael Aaron Grant 75,000 $0 +39.5%
Jun 05, 2026 Cahill Thomas Grant 75,000 $0 +39.5%
Jun 05, 2026 Chung Wendy Grant 75,000 $0 +39.5%
Jun 05, 2026 Marrazzo Jeffrey D Grant 75,000 $0 +39.5%
Jun 05, 2026 Schenkein David P Grant 75,000 $0 +39.5%
Apr 16, 2026 Makhni Svetlana Ni Grant 800,000 $0 +16.3%
Feb 26, 2026 Reine Allan Grant 1,300,000 $0 -2.5%
Feb 23, 2026 Alenson Carman Grant 140,000 $0 +27.8%

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Nov 05, 2026 Q3 2026 -$0.25
Oct 30, 2026 Q3 2026 -$0.25
Jun 30, 2026 Q2 2026 -$0.26 -$0.24 +8.6% Beat
Mar 31, 2026 Q1 2026 -$0.26 -$0.28 -9.6% Miss
Dec 31, 2025 Q4 2025 -$0.26 -$0.26 -1.4% Miss
Sep 30, 2025 Q3 2025 -$0.26 -$0.32 -24.0% Miss

Track PRME with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for PRME and your entire portfolio.